Cargando…
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells
Epithelial ovarian cancer (EOC) is a global health burden and remains the fifth leading cause of cancer related death in women worldwide with the poorest five-year survival rate of the gynecological malignancies. EOC recurrence is considered to be driven by the survival of chemoresistant, stem-like...
Autores principales: | Caminear, Michael W., Harrington, Brittney S., Kamdar, Rahul D., Kruhlak, Michael J., Annunziata, Christina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967967/ https://www.ncbi.nlm.nih.gov/pubmed/35372040 http://dx.doi.org/10.3389/fonc.2022.762820 |
Ejemplares similares
-
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2023) -
Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer
por: Tang, Bin, et al.
Publicado: (2023) -
Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
por: Harrington, Brittney S., et al.
Publicado: (2020) -
NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells
por: Kamdar, Rahul D., et al.
Publicado: (2023) -
Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors
por: Omran, Ziad
Publicado: (2022)